PAIN+ CPN

Flamer D, Alakkad H, Soneji N, et al. Comparison of two ultrasound-guided techniques for greater occipital nerve injections in chronic migraine: a double-blind, randomized, controlled trial. Reg Anesth Pain Med. 2019 Mar 18. pii: rapm-2018-100306. doi: 10.1136/rapm-2018-100306. (Original study)
Abstract

BACKGROUND AND OBJECTIVES: Two ultrasound (US)-guided techniques for greater occipital nerve (GON) block have been described for the management of headache disorders: a "proximal or central" technique targeting the GON at the level of the second cervical vertebra and a "distal or peripheral" technique targeting the GON at the level of the superior nuchal line. In this multicenter, prospective, randomized control trial, we compared accuracy, effectiveness, and safety of these two techniques in patients with chronic migraines (CMs).

METHODS: Forty patients with refractory CMs were randomized to receive either a proximal or distal US-guided GON block with bupivacaine and methylprednisolone acetate. The primary outcome was the difference in Numerical Rating Score (NRS) for headache intensity at 1 month. Secondary outcomes were effectiveness, performance, and safety-related. Effectiveness-related outcomes included NRS for headache intensity, number of headache days per week, patient satisfaction, quality of life, assessment of sleep quality, and sleep interruption. Performance-related outcomes included procedure time, accuracy of block, and patient discomfort. Safety-related outcomes included an assessment for adverse effects.

RESULTS: NRS pain scores were significantly reduced at 24 hours and at 1 week postprocedure in both cohorts and at 1 and 3 months in the proximal group as compared with the baseline. There was no significant difference in NRS pain scores between the two cohorts at any of the follow-up time points. There was a significant reduction in number of headache days per week at 1 month in both groups, and a significant improvement in sleep interruption at 1 week in both groups. There were no significant adverse effects.

CONCLUSIONS: This study was designed to compare two different US-guided approaches for blocking the GON. Our results demonstrate that both distal and proximal techniques can provide a short-term improvement in headache intensity, reduction in number of headache days per week, and an improvement in sleep interruption. The proximal GON technique may confer more sustained analgesic benefit compared with the distal approach in patients with CM headaches.

TRIAL REGISTRATION NUMBER: NCT02031822.

Ratings
Discipline Area Score
Physician 6 / 7
Show me more articles about:
  Headache   Migraine Headache
Comments from MORE raters

Physician rater

This is a very important study. Some patients with migraine can not achieved substantial pain reduction with oral medications. Pain intervention with US guided injection can be an option for some patients. The use of randomized, blind assessment, and complete of follow up are the strength of this study. Further studies with larger sample size are warranted.

Physician rater

This is a very interesting trial. The use of randomization allocation is the main strength of this study. The double blind measurement increase the validity of this study. The complete follow up also increase the validity. The result show that this 2 techniques are similar. Further trials with larger subjects are needed.
Comments from PAIN+ CPN subscribers

No subscriber has commented on this article yet.